Results 141 to 150 of about 31,542 (255)

TMPRSS2 Expression in Lung Tissue of Prostatic Adenocarcinoma Patients: Androgen Deprivation Therapy and Relevance to SARS-CoV-2 Infection. [PDF]

Curr Issues Mol Biol
Riveros Angel M, Loeffler D, Charifa A, Sinit RB, Amery T, Cengiz B, Beer TM, Thomas GV.   +7 more
europepmc   +1 more source

Serendipity for the intervention of COVID-19 and prostatic adenocarcinoma (PaC). [PDF]

Prostate Cancer Prostatic Dis, 2022
Naseer F, Ahmad T, Gul R, Anjum S.
europepmc   +1 more source

Micro‐ultrasonography‐ vs MRI‐targeted biopsy in prostate cancer: Updated systematic review and meta‐analysis

BJU International, EarlyView.
Objective To refine prostate cancer (PCa) pathways by comparing micro‐ultrasonography‐targeted biopsy (micro‐US‐TBx) with magnetic resonance imaging (MRI)‐TBx for detecting clinically significant PCa (csPCa) and by evaluating diagnostic accuracy (sensitivity, specificity, positive predictive value, negative predictive value).
José Pedro Cassemiro Micheleto, Tallys Ávila Suzuki, Lucas Amorim Santos, Luann Porpino Sales, Roberto Iglesias Lopes, Bárbara Miranda Martins, Bárbara Vieira Lima Aguiar Melão, Mauricio Dener Cordeiro, Walid Sharour, Walid Shabana, William Carlos Nahas, Leopoldo Alves Ribeiro Filho, Caio Vinicius Suartz   +12 more
wiley   +1 more source

Expression of cytokeratin 19 in prostatic adenocarcinoma: a systematic review. [PDF]

BMC Cancer
Shahshenas S, Hosseini SM, Yarmohammadi H, Soltanipur M, Jalali Nadoushan M.   +4 more
europepmc   +1 more source

Expansion of Lymphocytes from Prostatic Adenocarcinoma and Adjacent Nonmalignant Tissue. [PDF]

Prostate Cancer, 2022
Nguyen LT, Lo CS, Fyrsta M, Nie J, Yam JY, Yen PH, Le MX, Hersey K, Kenk M, Crumbaker M, Fleshner N, Kulkarni G, Hamilton R, Jewett M, Finelli A, Evans A, Sweet J, Ohashi PS, Joshua AM.   +18 more
europepmc   +1 more source

Multiparametric MRI in prostate cancer active surveillance: results from the Miami Active Surveillance Trial (MAST) trial

BJU International, EarlyView.
Objectives To examine the role of multiparametric magnetic resonance imaging (mpMRI) in enhancing prostate cancer (PCa) detection and selecting candidates for active surveillance (AS), given that its utility in monitoring disease progression remains unclear.
Seyed Hossein Hosseini Sharifi, Adam Williams, Jonathan T. Ryan, Tarek Ajami, Omri Falik Nativ, Sunwoo Han, Isildinha M. Reis, Nachiketh Soodana‐Prakash, Archan Khandekar, Sanjaya Swain, Oleksandr N. Kryvenko, Radka Stoyanova, Alan Pollack, Patricia R. Castillo, Bruno Nahar, Chad R. Ritch, Bruce Kava, Mark L. Gonzalgo, Dipen J. Parekh, Sanoj Punnen   +19 more
wiley   +1 more source

The Role of Prostate-Specific Membrane Antigen (PSMA) PET-CT in Characterizing Suspected Synchronous Rectal Lesions in a Case of High-Grade Prostatic Adenocarcinoma. [PDF]

Cureus
Sankar G, Tarafdar S, Halder A, Saha R, Tummidi S.   +4 more
europepmc   +1 more source

Covalent drug discovery: Progress against key targets, emerging strategies and lessons learnt

British Journal of Pharmacology, EarlyView.
Abstract Covalent drug discovery is currently experiencing a boom in industrial and academic interest. To date, at least 75 covalent drugs have received regulatory approval, targeting both traditional target classes and more challenging proteins for which other approaches failed. In many cases, unique aspects of covalent targeting are essential for the
Charles P. Brown, Alan Armstrong, David J. Mann   +2 more
wiley   +1 more source

Utilization of NKX3.1 and P501S to distinguish primary breast carcinoma from metastatic prostatic adenocarcinoma in male patients. [PDF]

Virchows Arch
Goksel M, Patel CR, Anderson SA, Carames GP, Moultrie SS, Magi-Galluzzi C, Wei S, Huang X, Huang X.   +8 more
europepmc   +1 more source

Metastatic Prostatic Adenocarcinoma Masquerading as Pulmonary Tuberculosis: A Case Report. [PDF]

Cureus, 2022
Vohra M, Lanjewar A, Upadhyay P, Jadhav U, Ghewade B.   +4 more
europepmc   +1 more source